-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MdgSNStVGhPVu/6Qh5MV2mj7Kjtcf9+IXomb7ReWNjsZ3OSfbah2pH87agguO1Im 1+8FZuhlWomxx1EibILXnw== 0001209191-07-036195.txt : 20070608 0001209191-07-036195.hdr.sgml : 20070608 20070608164214 ACCESSION NUMBER: 0001209191-07-036195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070607 FILED AS OF DATE: 20070608 DATE AS OF CHANGE: 20070608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALSERES PHARMACEUTICALS INC /DE CENTRAL INDEX KEY: 0000094784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870277826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 MAIN STREET CITY: HOPKINTON STATE: MA ZIP: 01748 BUSINESS PHONE: 508-497-2360 MAIL ADDRESS: STREET 1: 85 MAIN STREET CITY: HOPKINTON STATE: MA ZIP: 01748 FORMER COMPANY: FORMER CONFORMED NAME: BOSTON LIFE SCIENCES INC /DE DATE OF NAME CHANGE: 19950706 FORMER COMPANY: FORMER CONFORMED NAME: GREENWICH PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: STRATEGIC MEDICAL RESEARCH CORP /DE DATE OF NAME CHANGE: 19790521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAVAS PETER G CENTRAL INDEX KEY: 0001127426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-06533 FILM NUMBER: 07910260 BUSINESS ADDRESS: STREET 1: 110 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02173 BUSINESS PHONE: 6178624003 MAIL ADDRESS: STREET 1: 110 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02173 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2007-06-07 0 0000094784 ALSERES PHARMACEUTICALS INC /DE ALSE 0001127426 SAVAS PETER G 85 MAIN STREET HOPKINTON MA 01748 1 1 0 0 CHIEF EXECUTIVE OFFICER Stock Option (Right to Buy) 2.87 2007-06-07 4 A 0 200000 0.00 A 2017-06-06 Common Stock 200000 1150000 D Represents options granted by the issuer pursuant to its 2005 Stock Incentive Plan. The stock option will vest monthly in equal installments over three years. Includes multiple option grants with different exercise prices and vesting dates. /s/ Peter G. Savas 2007-06-08 -----END PRIVACY-ENHANCED MESSAGE-----